RYAHF (RYAH Group) NonCurrent Deferred Liabilities: $0.00 Mil (As of Sep. 2022)


What is RYAH Group NonCurrent Deferred Liabilities?

RYAH Group RYAHF NonCurrent Deferred Liabilities is $0.00 Mil as of Sep. 2022.

Non-Current Deferred Liabilities represents the non-current portion of obligations, which is a liability that usually would have been paid but is now pas due.

RYAH Group's non-current deferred liabilities for the quarter that ended in Sep. 2022 was $0.00 Mil.

RYAH Group NonCurrent Deferred Liabilities Related Terms

RYAH Group NonCurrent Deferred Liabilities Historical Data

* Premium members only.

The historical data trend for RYAH Group's NonCurrent Deferred Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

RYAH Group NonCurrent Deferred Liabilities Chart

RYAH Group Annual Data
Trend Dec20 Dec21
NonCurrent Deferred Liabilities
0.00 0.00

RYAH Group Quarterly Data
Feb20 Dec20 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22
NonCurrent Deferred Liabilities Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00
What does a NonCurrent Deferred Liabilities of $0.00 Mil mean?
RYAH Group (RYAHF) has a NonCurrent Deferred Liabilities of $0.00 Mil as of Sep. 2022. Non-current deferred liabilities represent the company obligations not paid yet not due within the current period. View historical data on RYAH Group and its competitors.
Is RYAH Group's NonCurrent Deferred Liabilities too high?
RYAH Group's current NonCurrent Deferred Liabilities is $0.00 Mil.
How does RYAH Group's NonCurrent Deferred Liabilities compare to CERN and VEEV?
RYAH Group's NonCurrent Deferred Liabilities of $0.00 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good NonCurrent Deferred Liabilities for a Healthcare Providers & Services company?
A good NonCurrent Deferred Liabilities depends on the Healthcare Providers & Services industry context. However, NonCurrent Deferred Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high NonCurrent Deferred Liabilities mean?
A high NonCurrent Deferred Liabilities can signal that a stock is expensive relative to its fundamentals. Non-current deferred liabilities represent the company obligations not paid yet not due within the current period. View historical data on RYAH Group and its competitors. RYAH Group's current NonCurrent Deferred Liabilities is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is RYAH Group stock overvalued right now?
RYAH Group (RYAHF) has a current NonCurrent Deferred Liabilities of $0.00 Mil. The current NonCurrent Deferred Liabilities is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is NonCurrent Deferred Liabilities calculated?
NonCurrent Deferred Liabilities is calculated from a company's financial statements. For RYAH Group (RYAHF), the current NonCurrent Deferred Liabilities is $0.00 Mil as of Sep. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

RYAH Group Business Description

Address 68 34TH STREET, SUITE B421, BROOKLYN, NY, USA, 11232
RYAH Group Inc is a data technology company in plant-based medicine. Its Artificial Intelligence platform aggregates and correlates HIPAA-compliant dosing data from seed to consumption. This helps the company to conduct predictive analyses to help doctors, researchers, and end-users create personalized dosing regimens that can accurately foresee patient outcomes. the company also provide other products which are smart inhaler system & smart patch system.